View in EDS HTML Full Text PDF Full Text

Comparative Cost-Effectiveness Analysis of Multiple First-Line Treatments for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer in Japan.

Saved in:

Bibliographic Details
Title:	Comparative Cost-Effectiveness Analysis of Multiple First-Line Treatments for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer in Japan.
Authors:	Morimoto, Kosuke^1,2 (AUTHOR) m.kousuke0117@gmail.com, Moriwaki, Kensuke^2,3 (AUTHOR), Nishikawa, Yoshitaka^1,4,5 (AUTHOR), Maeda, Tomomi^2,6 (AUTHOR), Toyama, Mayumi¹ (AUTHOR), Agatsuma, Nobukazu⁷ (AUTHOR), Kojima, Satomi² (AUTHOR), Utsumi, Takahiro⁷ (AUTHOR), Takahashi, Yoshimitsu⁸ (AUTHOR), Shimozuma, Kojiro² (AUTHOR), Nakayama, Takeo¹ (AUTHOR)
Source:	PharmacoEconomics - Open. May2026, Vol. 10 Issue 3, p471-489. 19p.
Database:	Business Source Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	25094254
DOI:	10.1007/s41669-025-00634-7